Skeletal muscle and whole body insulin resistance but not cardiac muscle insulin resistance could be improved by troglitazone therapy within 12 weeks in type-2 diabetes

ISSN Print: 1937-6871
ISSN Online: 1937-688X
www.scirp.net/journal/jbise
E-mail: [email protected]

Citations

"Skeletal muscle and whole body insulin resistance but not cardiac muscle insulin resistance could be improved by troglitazone therapy within 12 weeks in type-2 diabetes"
written by Ikuo Yokoyama, Toshiyuki Moritan, Yusuke Inoue,
published by Journal of Biomedical Science and Engineering, Vol.5 No.12A, 2012

has been cited by the following article(s):

[1]	Quantification, Variability, and Reproducibility of Basal Skeletal Muscle Glucose Uptake in Healthy Humans Using 18F-FDG PET/CT
	Journal of Nuclear Medicine, 2015

[2]	Quantification, variability, and reproducibility of basal skeletal muscle glucose uptake in healthy humans using 18 F-FDG PET/CT
	2015

[1]	Quantification, Variability, and Reproducibility of Basal Skeletal Muscle Glucose Uptake in Healthy Humans Using 18F-FDG PET/CT Journal of Nuclear Medicine, 2015 DOI:10.2967/jnumed.115.159715

[2]	Heart and skeletal muscle insulin resistance but not myocardial blood flow reserve could be related to chronic use of thiazolidione in patients with type-2 diabetes Journal of Biomedical Science and Engineering, 2013 DOI:10.4236/jbise.2013.62018

[3]	Myocardial insulin resistance does not always parallel skeletal muscle and whole body insulin resistance: A mini review —Myocardial Insulin Resistance Journal of Biomedical Science and Engineering, 2013 DOI:10.4236/jbise.2013.61005